Skip to content

OS Therapies OSTX Debt Instrument Issued Principal

Debt Instrument Issued Principal at other companies

OS Therapies logo
OS TherapiesOSTX
$27.5K
NMP
Nuveen Prem Inc Muni FundNMP
$150K
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
$314.49K
Lincoln National logo
Lincoln NationalLNC
$250M
KEE
Keel Infrastructure Corp. Common StockKEEL
$166.62M+39,220%
John Wiley & Sons, Inc. logo
John Wiley & Sons, Inc.WLYB
$265.26M+73.5%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentIssuedPrincipal.

The official record: OS Therapies’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's debt instrument issued principal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's debt instrument issued principal?
OS Therapies (OSTX) reported debt instrument issued principal of $27.5K in Q4 2025.
What does debt instrument issued principal mean?
This metric represents the total face value or principal amount of debt instruments issued by the company during the reporting period. It reflects the company's ability to access credit markets and its reliance on debt financing to support operations or capital requirements. Monitoring this figure helps investors assess the company's leverage strategy and future debt service obligations.